Home > Perspectives on drugs: Synthetic cannabinoids in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2017) Perspectives on drugs: Synthetic cannabinoids in Europe. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 9 p.

[img]
Preview
PDF (Synthetic cannabinoids in Europe) - Published Version
396kB

Synthetic cannabinoids represent the largest group of substances currently monitored in Europe by the EMCCDA through the EU Early Warning System. Current knowledge on these substances and trends in production, availability, use and harms are presented in this analysis.

Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.

Note that the online version contains additional interactive or audiovisual material not available in the PDF version

http://www.emcdda.europa.eu/publications/pods/synthetic-cannabinoids

Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Cannabis, New psychoactive substance
Date:June 2017
Pages:9 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Drugs and alcohol substances > Cannabis product (synthetic cannabinoids)
B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page